Remove Biotech Remove Development Remove Technology
article thumbnail

The Week’s 10 Biggest Funding Rounds: Crusoe Energy, Insider And Biotech Raise Big

Crunchbase News

startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. and AI product development. The latest startup in the space to get a big chunk of cash is Beta Technologies, maker of electric vertical take-off and landing planes.

Biotech 124
article thumbnail

Deep tech disruption: How advanced technologies are transforming businesses

CIO

From AI models that boost sales to robots that slash production costs, advanced technologies are transforming both top-line growth and bottom-line efficiency. Business leaders dont need to be technology experts to grasp this shift; they need vision and urgency. Crucially, the time and cost to implement AI have fallen.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 Since 1996 , 14,000 startups have licensed technology out of those universities, and 67% of licenses were taken by startups or small companies. Kevin O’Connor.

Biotech 240
article thumbnail

These Were The Winners And Losers In A Boring Year For Startup IPOs

Crunchbase News

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. The provider of AI and cloud connectivity technology was recently valued around $18 billion. Just a handful of U.S.

Biotech 119
article thumbnail

IPO Readiness: What Biotech Startups And Others Need To Know

Crunchbase News

Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.

Biotech 95
article thumbnail

5 ways biotech startups can mitigate risk to grow sustainably in the long run

TechCrunch

Omar Khalil is a partner at Santé Ventures , where he focuses primarily on biotechnology and medical technology companies. Capital is the fuel that advances scientific and technological innovation, and it means a life science startup can create products that benefit the world at large. Omar Khalil. Contributor. Share on Twitter.

Biotech 242